Globe Life Inc. shares dropped 6.1% after the insurer raised its full-year 2026 net operating earnings guidance to US$15.55–US$15.95 per diluted share and expanded share repurchases. The upgraded outlook reflects higher life underwriting margins, stronger health premiums, and excess investment income, along with potential remeasurement gains of US$110 million to US$130 million from life and health assumption updates. Second-quarter revenue reached US$1,599.73 million with net income of US$287.75 million, and the company bought back 1,100,000 shares for US$175 million in the latest quarter under a program totaling about US$10.42 billion. The muted share price reaction after earnings highlights how concerns about long term fundamentals can still weigh on sentiment even when results improve.
Globe Life IncShares fell 6.1% despite raised guidance and buybacks, indicating market concerns about long-term fundamentals.